Shunsuke Shigefuku

6PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCatalysis and mechanisms of reactionsGeospatial information systems and geospatial data modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2026
Maximum standardized uptake value significance in clinical stage IB-IIIB non-small cell lung cancer.

Shunsuke Shigefuku, Hiroyuki Ito, Yui Kaburaki

|Jul 10, 2024
Prognostic significance of immunotherapy in postoperative recurrent non-small cell lung cancer without EGFR mutations or ALK rearrangements.

Shunsuke Shigefuku, Satoshi Takahashi, Masaru Hagiwara

|Oct 25, 2022
Prognostic Significance of the Maximum Standardized Uptake Value on the Prognosis of Clinical Stage IA Lung Adenocarcinoma Based on the 8th Edition TNM Classification.

Shunsuke Shigefuku, Hiroyuki Ito, Jun Miura

|Oct 22, 2022
ASO Author Reflections: Is SUVmax Comparable with TNM Classification 8th Edition in Early-Stage Lung Adenocarcinoma?

Shunsuke Shigefuku

|Jan 18, 2022
Significance of very-low-voltage coagulation plus coverage with polyglycolic acid sheet after bullectomy for primary spontaneous pneumothorax.

Shunsuke Shigefuku, Hidenobu Takahashi, Maki Ito

|Jun 15, 2021
Reply to "Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients" by Guowei Che et al.

Shunsuke Shigefuku

Pageof 1

Frequent Collaborators